Nitric oxide synthase expression, enzyme activity and NO production duringangiogenesis in the chick chorioallantoic membrane

Citation
E. Pipili-synetos et al., Nitric oxide synthase expression, enzyme activity and NO production duringangiogenesis in the chick chorioallantoic membrane, BR J PHARM, 129(1), 2000, pp. 207-213
Citations number
37
Categorie Soggetti
Pharmacology & Toxicology
Journal title
BRITISH JOURNAL OF PHARMACOLOGY
ISSN journal
00071188 → ACNP
Volume
129
Issue
1
Year of publication
2000
Pages
207 - 213
Database
ISI
SICI code
0007-1188(200001)129:1<207:NOSEEA>2.0.ZU;2-4
Abstract
1 In order to elucidate further the role of nitric oxide (NO) as an endogen ous antiangiogenic mediator, mRNA expression of inducible nitric oxide synt hase (iNOS), enzyme activity and production of NO were determined in the ch ick chorioallantoic membrane (CAM), an in vivo model of angiogenesis. In th is model, maximum angiogenesis is reached between days 9-12 of chick embryo development. After that period, vascular density remains constant. 2 Inducible NO synthase (iNOS) mRNA expression, determined by reverse trans criptase polymerase chain reaction (RT-PCR), increased from the 8th day rea ching a maximum (70% increase) at days 10-11. 3 NO synthase activity, determined as citrulline formation in the presence of calcium, also increased from day 8 reaching a maximum around day 10 (100 % increase). Similar results were obtained in the absence of calcium sugges ting that the NOS determined was the inducible form. 4 Nitric oxide production, determined as nitrites, increased from day 8 rea ching a maximum around day 10 (64% increase) and remaining stable at day 13 . 5 Finally, the bacterial lipopolysaccharide LPS (which activates transcript ionally iNOS), inhibited dose dependently angiogenesis in the CAM. These re sults in connection with previous findings from this laboratory, showing th at NO inhibits angiogenesis in the CAM, suggest that increases in iNOS expr ession, enzyme activity and NO production closely parallel the progression of angiogenesis in the CAM, thus providing an endogenous brake to control t his process.